Quality Improvement Implementation for Lung Cancer Screening (QUILS) Program Enhancement

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The initiative audits participating lung cancer screening programs to assess elements linked with higher quality and better patient retention. A feedback report is generated to highlight priorities for process improvement. Programs receive the QUILS System and participate in index assessments, audit feedback presentations, and formative interviews to understand how to optimize screening workflows. The study focuses on optimization rather than a new medical treatment, using structured feedback and evaluation to drive improvements. It is implemented across several Kentucky clinical sites led by Timothy Mullett.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Participants in Lung Cancer Screening Program, including physicians, nurses, administrators and other staff responsible for the conduct of the program.
* Willing to participate in the QUILS Index Assessment Survey process
* Willing to participate in the QUILS Audit Feedback presentations Willing to participate in formative evaluation interviews

Exclusion Criteria:

* Unwilling to participate in the QUILS Index Assessment Survey process
* Unwilling to participate in the QUILS Audit Feedback presentations
* Unwilling to participate in formative evaluation interviews

Where it's running

• King's Daughter's Medical Center
  Ashland, Kentucky, United States Recruiting
• Taylor Regional Hospital
  Campbellsville, Kentucky, United States Recruiting
• St. Elizabeth Healthcare
  Edgewood, Kentucky, United States Recruiting
• Georgetown Cancer Treatment Cancer
  Georgetown, Kentucky, United States Recruiting
• TJ Samson Community Hospital
  Glasgow, Kentucky, United States Recruiting
• Hazard Appalachian Regional Healthcare Medical Center
  Hazard, Kentucky, United States Recruiting

Study contacts

• Study coordinator: Joseph Alexander, MD
• Email: joseph.alexander@uky.edu
• Phone: 8593230892

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Empowering patients to get lung cancer screening with support and navigation

  This pilot study tests a patient navigation and education program to see if it helps adults who are eligible start and complete low-dose CT lung cancer screening.

  Recruiting at 13 sites University of California, Irvine · Anaheim, California and 56 other locations · NCT07711691

• Quality Implementation of Lung Cancer Screening in Kentucky

  This project tests how well the QUILS system helps Kentucky lung cancer screening programs work together to screen at-risk residents more effectively.

  Recruiting at 17 sites University of Kentucky · Ashland, Kentucky and 16 other locations · NCT07682610

• Statewide Lung Cancer Screening Improvement in Nevada and Mississippi using the QUILS System

  This project tests whether a QUILS-based statewide initiative can expand and sustain high-quality lung cancer screening for people in Mississippi and Nevada.

  Recruiting at 13 sites University of Kentucky · Greenville, Mississippi and 12 other locations · NCT07682597

• Methylation markers from saliva to guide lung cancer screening

  This study tests whether DNA methylation patterns in saliva can more accurately identify people who should get a low-dose CT scan for lung cancer screening.

  Recruiting University Hospital, Antwerp · Antwerp, Antwerpen · NCT07631624

• Multilevel program to increase LDCT lung cancer screening and help African American smokers quit

  This program will try combining low-dose CT screening with culturally tailored smoking-cessation support to help African American smokers who are eligible for LDCT quit and get screened.

  Recruiting at 2 sites Louisiana State University Health Sciences Center in New Orleans · New Orleans, Louisiana and 1 other locations · NCT07576595

• Precision lung cancer screening using AI risk scores and blood biomarkers

  This project will test whether the Sybil AI tool and optional blood tests can better predict lung cancer risk for people aged 50–80 getting low-dose CT scans, including those who meet expanded screening rules beyond current USPSTF guidance.

  Recruiting at 2 sites University of Illinois Chicago · Chicago, Illinois and 1 other locations · NCT07408531

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.